Progress in human tumour immunology and immunotherapy
- PMID: 11357146
- DOI: 10.1038/35077246
Progress in human tumour immunology and immunotherapy
Abstract
Studies of the administration of interleukin-2 to patients with metastatic melanoma or kidney cancer have shown that immunological manipulations can mediate the durable regression of metastatic cancer. The molecular identification of cancer antigens has opened new possibilities for the development of effective immunotherapies for patients with cancer. Clinical studies using immunization with peptides derived from cancer antigens have shown that high levels of lymphocytes with anti-tumour activity can be raised in cancer-bearing patients. Highly avid anti-tumour lymphocytes can be isolated from immunized patients and grown in vitro for use in cell-transfer therapies. Current studies are aimed at understanding the mechanisms that enable the cancer to escape from immune attack.
Similar articles
-
[Perspectives for tumour immunology: antigen-specific immunotherapy of malignant diseases].Dtsch Med Wochenschr. 2001 Sep 14;126(37):1011-6. doi: 10.1055/s-2001-17111. Dtsch Med Wochenschr. 2001. PMID: 11555776 Review. German. No abstract available.
-
Cancer vaccines: preclinical studies and novel strategies.Adv Cancer Res. 2006;95:115-45. doi: 10.1016/S0065-230X(06)95004-0. Adv Cancer Res. 2006. PMID: 16860657 Review.
-
The development of new cancer therapies based on the molecular identification of cancer regression antigens.Cancer J Sci Am. 1995 Jul-Aug;1(2):90-100. Cancer J Sci Am. 1995. PMID: 9166458 Review.
-
Immunotherapy of melanoma.Semin Cancer Biol. 2003 Dec;13(6):391-400. doi: 10.1016/j.semcancer.2003.09.001. Semin Cancer Biol. 2003. PMID: 15001157 Review.
-
[Immunotherapy for cancer--modern immunologic strategies in oncology].Dtsch Med Wochenschr. 2008 Oct;133(41):2105-8. doi: 10.1055/s-0028-1091251. Epub 2008 Oct 1. Dtsch Med Wochenschr. 2008. PMID: 18985564 Review. German.
Cited by
-
Harnessing the Microbiome to Enhance Cancer Immunotherapy.J Immunol Res. 2015;2015:368736. doi: 10.1155/2015/368736. Epub 2015 May 25. J Immunol Res. 2015. PMID: 26101781 Free PMC article. Review.
-
Local expression of interleukin-2 by B16 melanoma cells results in decreased tumour growth and long-term tumour dormancy.Immunology. 2013 Mar;138(3):280-92. doi: 10.1111/imm.12037. Immunology. 2013. PMID: 23198850 Free PMC article.
-
In Situ Conversion of Melanoma Lesions into Autologous Vaccine by Intratumoral Injections of α-gal Glycolipids.Cancers (Basel). 2010;2(2):773-93. doi: 10.3390/cancers2020773. Epub 2010 May 4. Cancers (Basel). 2010. PMID: 23087817 Free PMC article.
-
Prognostic role of platelet-lymphocyte ratio in colorectal cancer: A systematic review and meta-analysis.Medicine (Baltimore). 2016 Jun;95(24):e3837. doi: 10.1097/MD.0000000000003837. Medicine (Baltimore). 2016. PMID: 27310960 Free PMC article. Review.
-
Comprehensive comparative analysis of prognostic value of serum systemic inflammation biomarkers for colorectal cancer: Results from a large multicenter collaboration.Front Immunol. 2023 Jan 5;13:1092498. doi: 10.3389/fimmu.2022.1092498. eCollection 2022. Front Immunol. 2023. PMID: 36685502 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources